5-Minute Clinical Consult

Disseminated Intravascular Coagulation (DIC)

Disseminated Intravascular Coagulation (DIC) was found in 5-Minute Clinical Consult which helps you diagnose, treat, and follow up on over 900 medical conditions seen in everyday practice.

To view this entire topic, please or purchase a subscription.

Explore 5-Minute Clinical Consult - view these FREE monographs:

5-Minute Clinical Consult

-- The first section of this topic is shown below --

Basics

Description

  • Acquired syndrome characterized by diffuse activation of intravascular coagulation. It can originate from and cause damage to the microvasculature, which, if sufficiently severe, can produce organ dysfunction.
  • Occurs as a complication of pregnancy (e.g., abruptio placentae, fetus retention, amniotic fluid embolism), infection (especially gram-negative), malignancy (uncontrolled, metastatic tumor or leukemia), trauma, and other severe illnesses
  • System(s) affected: Hematologic/Lymphatic/Immunologic
  • Synonym(s): Consumptive coagulopathy; DIC

Epidemiology

Incidence
Unknown

Prevalence
  • Predominant age: None
  • Predominant sex: Male = Female

Risk Factors

See “Etiology.”

General Prevention

Aggressive interventions aimed at early treatment of the underlying clinical conditions

Pathophysiology

  • Systemic formation of fibrin is the result of the simultaneous coexistence of:
    • Increased thrombin generation via tissue factor-/factor VII-mediated pathway
    • Suppression of the physiologic anticoagulant pathways:
      • Antithrombin due to consumption, degradation, and impaired synthesis
      • Proteins C and S due to decreased levels of thrombomodulin
    • Impaired fibrinolysis (early on):
      • Sustained increase in plasminogen activator inhibitor, type 1
  • Increased fibrinolysis (late during the process) leads to bleeding.

Etiology

Causes can be classified as acute or chronic, systemic or localized:

  • Sepsis/Severe infection (any microorganism)
  • Trauma (polytrauma, neurotrauma)
  • Obstetric complications (amniotic fluid embolism, abruptio placentae)
  • Solid tumors and leukemias (especially acute promyelocytic leukemia)
  • Vascular disorders, such as Kasabach-Merritt syndrome, large vascular aneurysms, and thrombosis
  • Organ destruction (severe pancreatitis, severe liver failure)
  • Severe toxic or immunologic reactions:
    • Snake bite
    • Recreational drugs
    • Transfusion reactions
    • Transplant rejection
    • Thermal injury
  • Infant and adult respiratory distress syndrome
  • Neonatal purpura fulminans

Commonly Associated Conditions

Thromboembolic phenomena are associated with venous thrombosis, thrombotic vegetations on the aortic heart valve, arterial emboli, and neonatal purpura fulminans (homozygous protein C or protein S deficiency).

Pediatric Considerations
Neonatal purpura fulminans is associated with DIC and protein C or protein S deficiency (homozygous).

-- To view the remaining sections of this topic, please or purchase a subscription --